866-997-4948(US-Canada Toll Free)

BioMimetic Therapeutics, Inc. (BMTI) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Apr 2012

Category :

Surgical Equipment

No. of Pages : 58 Pages


BioMimetic Therapeutics, Inc. (BioMimetic) is a biotechnology company utilizing purified recombinant human platelet-derived growth factor (rhPDGF-BB) in combination with tissue specific matrices as its primary technology platform for promotion of tissue healing and regeneration. It is involved in the development and commercialization of drug-device combination products that enhance the healing of orthopedic, periodontal, craniofacial and sports injuries. Further, the companys range of products and product candidates combine recombinant protein therapeutics with tissue specific scaffolds that stimulate tissue healing and regeneration. 

It also follows a strategy of making alliance with others in the healthcare industry for ensuring development, promotion and reach of its products in other geographies. As a part of the strategy, it has manufacturing supply agreements involving the two principal components, rhPDGF and ß-TCP, of GEM 21S from the manufacturers of FDA approved products. Also, the company maintains contractual obligations for supply agreements with Novartis, Kensey Nash and Cam Bioceramics B.V. The company is headquartered in Franklin, US.

This report is a source for data, analysis and actionable intelligence on the BioMimetic Therapeutics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 5
BioMimetic Therapeutics, Inc. - Business Description 6
Key Facts 7
BioMimetic Therapeutics, Inc. - Major Products and Services 8
BioMimetic Therapeutics, Inc. Pipeline Products by Equipment Type 9
BioMimetic Therapeutics, Inc. Pipeline Products by Development Stage 11
BioMimetic Therapeutics, Inc. Pipeline Products by Therapy Area 13
BioMimetic Therapeutics, Inc. Pipeline Products by Trial Phase 15
BioMimetic Therapeutics, Inc. Pipeline Products by Milestone Summary 17
Augment - Acute Tendon 20
Augment - Acute Tendon Product Status 20
Augment - Acute Tendon Product Description 20
Augment - Acute Tendon Product Patent Details 20
Augment - Chronic Tendon 23
Augment - Chronic Tendon Product Status 23
Augment - Chronic Tendon Product Description 23
Augment - Chronic Tendon Product Patent Details 23
Augment - Spine 26
Augment - Spine Product Status 26
Augment - Spine Product Description 26
Augment - Spine Product Patent Details 26
Augment Bone Graft 29
Augment Bone Graft Product Status 29
Augment Bone Graft Product Description 29
Augment Bone Graft Product Milestone 30
Augment Bone Graft Product Patent Details 31
Augment Cartilage Repair 34
Augment Cartilage Repair Product Status 34
Augment Cartilage Repair Product Description 34
Augment Cartilage Repair Product Patent Details 34
Augment Injectable Bone Graft 37
Augment Injectable Bone Graft Product Status 37
Augment Injectable Bone Graft Product Description 37
Augment Injectable Bone Graft Product Milestone 37
Augment Injectable Bone Graft Product Patent Details 38
Augment Rotator Cuff Graft 41
Augment Rotator Cuff Graft Product Status 41
Augment Rotator Cuff Graft Product Description 41
Augment Rotator Cuff Graft Product Patent Details 41
Augment Tendon/Ligament Repair 44
Augment Tendon/Ligament Repair Product Status 44
Augment Tendon/Ligament Repair Product Description 44
Augment Tendon/Ligament Repair Product Patent Details 44
BioMimetic Therapeutics, Inc. - Key Competitors 47
BioMimetic Therapeutics, Inc. - Key Employees 48
BioMimetic Therapeutics, Inc. - Key Employee Biographies 49
BioMimetic Therapeutics, Inc. - Locations And Subsidiaries 50
Head Office 50
Other Locations & Subsidiaries 50
Recent Developments 51
BioMimetic Therapeutics, Inc., Recent Developments 51
Mar 13, 2012: BioMimetic Reports Revenue Of $1.7m In 2011 51
Feb 08, 2012: BioMimetic To Introduce Augmatrix Biocomposite Bone Graft Product Line At AAOS 51
Nov 08, 2011: BioMimetic Reports Q3 2011 Results 52
Aug 04, 2011: BioMimetic Reports Q2 2011 Results 53
Jul 08, 2011: Izard Nobel Announces Class Action Lawsuit Against BioMimetic Therapeutics 53
Jul 07, 2011: Harwood Feffer Announces Class Action Lawsuit Against Biomimetic 53
May 09, 2011: BioMimetic Reports Q1 2011 Results 54
Mar 10, 2011: BioMimetic Reports Total Revenues Of $1.5m In 2010 55
Feb 17, 2011: BioMimetic Therapeutics Highlights Commercial And Product Development Activities During AAOS 56

Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Table


BioMimetic Therapeutics, Inc., Key Facts 1
BioMimetic Therapeutics, Inc. Key Pipeline Products by Equipment Type 1
BioMimetic Therapeutics, Inc. Key Pipeline Products by Therapy Area 1
BioMimetic Therapeutics, Inc. Key Pipeline Products by Development Stage 1
BioMimetic Therapeutics, Inc. Key Pipeline Products by Trial Phase 1
BioMimetic Therapeutics, Inc., Key Facts 7
BioMimetic Therapeutics, Inc., Major Products and Services 8
BioMimetic Therapeutics, Inc. Number of Pipeline Products by Equipment Type 9
BioMimetic Therapeutics, Inc. Pipeline Products by Equipment Type 10
BioMimetic Therapeutics, Inc. Number of Pipeline Products by Development Stage 11
BioMimetic Therapeutics, Inc. Pipeline Products by Development Stage 12
BioMimetic Therapeutics, Inc. Number of Pipeline Products by Therapy Area 13
BioMimetic Therapeutics, Inc. Pipeline Products by Therapy Area 14
BioMimetic Therapeutics, Inc. Number of Pipeline Products by Trial Phase 15
BioMimetic Therapeutics, Inc. Pipeline Products by Trial Phase 16
BioMimetic Therapeutics, Inc. Number of Pipeline Products By Milestone Summary 17
BioMimetic Therapeutics, Inc. Pipeline Products by Milestone Summary 18
Augment - Acute Tendon - Product Status 20
Augment - Acute Tendon - Product Description 20
Augment - Acute Tendon - Patent Details 20
Augment - Chronic Tendon - Product Status 23
Augment - Chronic Tendon - Product Description 23
Augment - Chronic Tendon - Patent Details 23
Augment - Spine - Product Status 26
Augment - Spine - Product Description 26
Augment - Spine - Patent Details 26
Augment Bone Graft - Product Status 29
Augment Bone Graft - Product Description 29
Augment Bone Graft - Product Milestone 30
Augment Bone Graft - Patent Details 31
Augment Cartilage Repair - Product Status 34
Augment Cartilage Repair - Product Description 34
Augment Cartilage Repair - Patent Details 34
Augment Injectable Bone Graft - Product Status 37
Augment Injectable Bone Graft - Product Description 37
Augment Injectable Bone Graft - Product Milestone 37
Augment Injectable Bone Graft - Patent Details 38
Augment Rotator Cuff Graft - Product Status 41
Augment Rotator Cuff Graft - Product Description 41
Augment Rotator Cuff Graft - Patent Details 41
Augment Tendon/Ligament Repair - Product Status 44
Augment Tendon/Ligament Repair - Product Description 44
Augment Tendon/Ligament Repair - Patent Details 44
BioMimetic Therapeutics, Inc., Key Employees 48
BioMimetic Therapeutics, Inc., Key Employee Biographies 49
BioMimetic Therapeutics, Inc., Subsidiaries 50

List of Chart


BioMimetic Therapeutics, Inc. Key Pipeline Products by Equipment Type 1
BioMimetic Therapeutics, Inc. Pipeline Products by Equipment Type 9
BioMimetic Therapeutics, Inc. Pipeline Products by Development Stage 11
BioMimetic Therapeutics, Inc. Pipeline Products by Therapy Area 13
BioMimetic Therapeutics, Inc. Pipeline Products by Trial Phase 15
BioMimetic Therapeutics, Inc. Pipeline Products by Milestone Summary 17

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *